4237 |
[Debate: Left Main Disease - How to Treat in Contemporary Era?] LM Is Still Surgical Disease. |
David Paul Taggart |
Apr. 25. 17 |
4236 |
A Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease: DELTA II |
Davide Capodanno |
Apr. 25. 17 |
4235 |
New Meta-Analysis of RCTs in LM Revascularization |
Tullio Palmerini |
Apr. 25. 17 |
4234 |
How Do I Choose Sapien 3, Evolut R or Lotus in My Practice? |
Duk-Woo Park |
Apr. 25. 17 |
4233 |
TAVR for Low Risk and Younger Patients |
Horst Sievert |
Apr. 25. 17 |
4232 |
Bicuspid AS: Future Perspectives of TAVR |
Jung-Min Ahn |
Apr. 25. 17 |
4231 |
Stroke in Aortic Valve Interventions |
E Murat Tuzcu |
Apr. 25. 17 |
4230 |
Complication: Status, Prediction, and Prevention |
Corrado Tamburino |
Apr. 25. 17 |
4229 |
TAVR with or Without Predilatation |
Kentaro Hayashida |
Apr. 25. 17 |
4228 |
DEB an Alternative in De Novo and Small Vessel Disease |
Amin Ariff Nuruddin |
Apr. 25. 17 |